Early Intervention to Prevent Lower Limb Lymphedema of Gynecological Malignancy
NCT05793749 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2023-03-31
Summary
This study is a prospective, randomized, controlled clinical trial of a single center in China and plans to enroll 400 patients.
1. Patients with diagnosed gynecological malignancies who underwent pelvic and abdominal lymphadenectomy and required pelvic radiotherapy;
2. Random grouping (A:B=3:1): A. Prophylactic lymphoedema treatment; B. Standard care group;
3. Preventive lymphedema health education was given to patients with gynecological malignant tumors without contraindications before surgery. All patients were randomly divided into an intervention group and a nonintervention group. The intervention group received preventive lymphedema treatment twice a week. 10 times, and the interval between the two treatments was not less than 48 hours and not more than 2 weeks. The intervention measures included four parts: manual lymphatic drainage, skin care, functional exercise, and wearing lymphedema preventive compression stockings. In the nonintervention group, knowledge education and telephone follow-up were routinely conducted.
4. All patients were evaluated for edema, lymphedema symptoms and quality of life 1 day before radiotherapy, every Friday during radiotherapy and every 3 months thereafter. Bioelectrical impedance measurement and leg diameter measurement were used to evaluate edema, the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) was used to evaluate lymphedema symptoms, and the EORTC Quality of Life Scale (QLQ-C30) was used to evaluate quality of life. followed up to 2 years after the end of lymphedema prophylaxis.
Conditions
- Uterine Cervical Neoplasms
- Endometrial Neoplasms
- Lymphedema
- Treatment Effectiveness
Interventions
- BEHAVIORAL
-
Prophylactic lymphedema treatment
1\. perform manual lymphatic drainage twice a week after the start of radiotherapy for a total of 10 times, and wear lymphedema compression stockings after each manual lymphatic drainage, 2. teach patients how to care for their skin. 3. perform functional exercises for lymphedema of the lower extremities twice a day for 15 \~ 20 minutes each time. 4. follow up observation: before the start of radiotherapy, every Friday during radiotherapy, and every 3 months after the end of radiotherapy, the occurrence of lymphedema and related symptoms and quality of life were evaluated.
Sponsors & Collaborators
-
Chongqing University Cancer Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-01
- Primary Completion
- 2026-07-29
- Completion
- 2026-07-29
Countries
- China
Study Locations
More Related Trials
-
Evaluation of the Efficacy for Sentinel Lymph Node Policy in High-risk Endometrial Carcinoma
NCT03716414 ·Status: COMPLETED
-
Study of Cryoablation for Metastatic Lung Tumors
NCT01957787 ·Status: COMPLETED ·Phase: NA
-
Feasibility, Safety, and Efficacy of Stereotactic MRI-Guided Adaptive Radiation Therapy (SMART) for Central Lung Tumors
NCT05609331 ·Status: TERMINATED ·Phase: NA
-
Bone Toxicity Following Pelvic Radiotherapy
NCT04555317 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer
NCT00349102 ·Status: COMPLETED ·Phase: PHASE3
-
Prophylactic Irradiation of the Para-Aortic Lymph Nodes in Locally Advanced Uterine Cervical Cancer
NCT00980759 ·Status: UNKNOWN ·Phase: NA
-
Analysis of Percutaneous Ablations for Cancer Treatment
NCT01563679 ·Status: COMPLETED
-
RT for Adenocarcinoma/Adenosquamous Carcinoma
NCT07153952 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma (SPARE-01)
NCT05167994 ·Status: RECRUITING ·Phase: PHASE2
-
Effect of Triple Pre-rehabilitation on Radiotherapy for Head and Neck Cancer Patients
NCT05594069 ·Status: COMPLETED ·Phase: NA
-
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)
NCT05224934 ·Status: RECRUITING ·Phase: NA
-
Longitudinal Study of Local Ablative Therapy in Oligometastatic Disease
NCT06356779 ·Status: RECRUITING ·Phase: NA
-
Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer
NCT05802641 ·Status: UNKNOWN
-
Tumor Response in Hypofractionated Radiotherapy
NCT02854449 ·Status: UNKNOWN
-
Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
NCT00589121 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Non-magnetic Screen Respiratory Self-guidance During MRI-guided Radiotherapy Sessions for Mobile Lesions
NCT05783908 ·Status: RECRUITING ·Phase: NA
-
Study Comparing Negative Pressure Dressing vs Conventional in Patients With Resected STS After Radiotherapy
NCT05944913 ·Status: RECRUITING ·Phase: NA
-
Radiofrequency Ablation of Pulmonary Tumors Response Evaluation
NCT00690703 ·Status: COMPLETED ·Phase: PHASE2
-
Prediction Model for Lateral Lymph Node Metastasis
NCT04635488 ·Status: UNKNOWN
-
Preventive Physical Activity Intervention in Head and Neck Cancer
NCT05432297 ·Status: RECRUITING ·Phase: NA
-
Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study
NCT05602974 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Multiparametric Quantitative MRI and Response to Neoadjuvant Radiotherapy for Soft-tissue Sarcoma
NCT05684874 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
NCT06760221 ·Status: RECRUITING ·Phase: NA
-
A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma
NCT03416803 ·Status: UNKNOWN ·Phase: NA
-
Sentinel Lymph Node Detection in Endometrial Cancer
NCT02690259 ·Status: COMPLETED ·Phase: NA